DK1240901T3 - Medicinske præparater til behandling og forebyggelse af sygdomme baseret på abnorm blodkoagulation - Google Patents
Medicinske præparater til behandling og forebyggelse af sygdomme baseret på abnorm blodkoagulationInfo
- Publication number
- DK1240901T3 DK1240901T3 DK00987688T DK00987688T DK1240901T3 DK 1240901 T3 DK1240901 T3 DK 1240901T3 DK 00987688 T DK00987688 T DK 00987688T DK 00987688 T DK00987688 T DK 00987688T DK 1240901 T3 DK1240901 T3 DK 1240901T3
- Authority
- DK
- Denmark
- Prior art keywords
- blood coagulation
- prevention
- treatment
- disorders
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36812299A JP4676585B2 (ja) | 1999-12-24 | 1999-12-24 | 血液凝固異常に基づく疾患の治療・予防用医薬組成物 |
PCT/JP2000/009102 WO2001047548A1 (fr) | 1999-12-24 | 2000-12-21 | Compositions medicinales de traitement et de prevention de maladies basees sur une coagulation sanguine anormale |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1240901T3 true DK1240901T3 (da) | 2008-11-10 |
Family
ID=18491024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00987688T DK1240901T3 (da) | 1999-12-24 | 2000-12-21 | Medicinske præparater til behandling og forebyggelse af sygdomme baseret på abnorm blodkoagulation |
Country Status (9)
Country | Link |
---|---|
US (1) | US6881721B2 (da) |
EP (1) | EP1240901B1 (da) |
JP (1) | JP4676585B2 (da) |
CN (1) | CN1222311C (da) |
AT (1) | ATE407692T1 (da) |
DE (1) | DE60040236D1 (da) |
DK (1) | DK1240901T3 (da) |
ES (1) | ES2312374T3 (da) |
WO (1) | WO2001047548A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1407780T3 (da) * | 2001-07-10 | 2013-05-13 | Chemo Sero Therapeut Res Inst | Farmaceutisk stabile hæmostatiske præparater |
JP2007055899A (ja) * | 2003-10-27 | 2007-03-08 | Chemo Sero Therapeut Res Inst | 血液凝固第x因子を主剤とする血液凝固異常に基づく疾患の治療・予防用医薬組成物 |
US20090053193A1 (en) * | 2004-05-11 | 2009-02-26 | Novo Nordisk Healthcare A/G | Use of Factor VIIa for the Treatment of Burn Trauma |
WO2008023052A1 (en) * | 2006-08-24 | 2008-02-28 | Novo Nordisk Health Care Ag | Combination of a fvii and a thrombin-activable factor x |
EP2201953A4 (en) * | 2007-08-27 | 2011-08-03 | Univ Nagoya Nat Univ Corp | USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER |
US10147152B2 (en) | 2010-04-08 | 2018-12-04 | Hemosonics, Llc | Hemostatic parameter display |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0044343B1 (en) | 1980-01-28 | 1984-08-22 | Baxter Travenol Laboratories, Inc. | Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions |
US4287180A (en) * | 1980-01-28 | 1981-09-01 | Baxter Travenol Laboratories, Inc. | Method for treating blood clotting factor inhibitors |
US4663164A (en) * | 1980-01-28 | 1987-05-05 | Baxter Travenol Laboratories, Inc. | Aqueous compositions for treating blood clotting factor inhibitors |
US4286056A (en) * | 1980-01-28 | 1981-08-25 | Baxter Travenol Laboratories, Inc. | Method for making therapeutic enzyme compositions |
US4357321A (en) * | 1980-01-28 | 1982-11-02 | Baxter Travenol Laboratories, Inc. | Method and composition for treating clotting factor inhibitors |
US4459288A (en) * | 1981-05-11 | 1984-07-10 | Baxter Travenol Laboratories, Inc. | Therapeutic blood clotting factor compositions and their use |
US4382083A (en) * | 1981-06-25 | 1983-05-03 | Baxter Travenol Laboratories, Inc. | Therapeutic method for treating blood-clotting defects with factor VIIa |
US4501731A (en) * | 1983-06-27 | 1985-02-26 | Tishkoff Garson H | Treatment of disparate bleeding disorders with factor X zymogen |
JP2824430B2 (ja) | 1989-08-02 | 1998-11-11 | 財団法人化学及血清療法研究所 | 血液凝固第▲vii▼因子または活性型血液凝固第▲vii▼因子の調製方法 |
DE4325872C1 (de) | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
AU697205B2 (en) * | 1994-04-22 | 1998-10-01 | Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis | Method and means for detecting and treating disorders in the blood coagulation cascade |
DE19531637A1 (de) | 1995-08-28 | 1997-03-06 | Immuno Ag | Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung |
JP4046377B2 (ja) | 1996-08-19 | 2008-02-13 | 財団法人化学及血清療法研究所 | 血液凝固第vii因子の活性化方法及び該方法に基づく活性化血液凝固第vii因子の製造方法 |
JPH1059866A (ja) | 1996-08-19 | 1998-03-03 | Chemo Sero Therapeut Res Inst | 血液凝固第vii因子及び/もしくは活性化血液凝固第vii因子の製造方法 |
-
1999
- 1999-12-24 JP JP36812299A patent/JP4676585B2/ja not_active Expired - Lifetime
-
2000
- 2000-12-21 DK DK00987688T patent/DK1240901T3/da active
- 2000-12-21 CN CNB008190976A patent/CN1222311C/zh not_active Expired - Lifetime
- 2000-12-21 DE DE60040236T patent/DE60040236D1/de not_active Expired - Lifetime
- 2000-12-21 AT AT00987688T patent/ATE407692T1/de active
- 2000-12-21 US US10/168,371 patent/US6881721B2/en not_active Expired - Lifetime
- 2000-12-21 EP EP00987688A patent/EP1240901B1/en not_active Expired - Lifetime
- 2000-12-21 ES ES00987688T patent/ES2312374T3/es not_active Expired - Lifetime
- 2000-12-21 WO PCT/JP2000/009102 patent/WO2001047548A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP4676585B2 (ja) | 2011-04-27 |
WO2001047548A1 (fr) | 2001-07-05 |
JP2001181204A (ja) | 2001-07-03 |
US6881721B2 (en) | 2005-04-19 |
CN1434720A (zh) | 2003-08-06 |
CN1222311C (zh) | 2005-10-12 |
EP1240901B1 (en) | 2008-09-10 |
DE60040236D1 (de) | 2008-10-23 |
US20030060411A1 (en) | 2003-03-27 |
EP1240901A4 (en) | 2005-01-12 |
EP1240901A1 (en) | 2002-09-18 |
ATE407692T1 (de) | 2008-09-15 |
ES2312374T3 (es) | 2009-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bidolegui et al. | Tranexamic acid reduces blood loss and transfusion in patients undergoing total knee arthroplasty without tourniquet: a prospective randomized controlled trial | |
Ramström et al. | Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants | |
DK0913156T3 (da) | Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis | |
DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
HUP0301729A2 (hu) | Gyógyszer szívelégtelenség megelżzésére és kezelésére | |
MY125150A (en) | Factor vlla inhibitors | |
Liu et al. | Tranexamic acid reduces occult blood loss, blood transfusion, and improves recovery of knee function after total knee arthroplasty: a comparative study | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
HUP0401501A2 (hu) | Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával | |
WO2007106893A3 (en) | Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors | |
Pachauri et al. | The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty | |
Kapadia et al. | Reducing perioperative blood loss with antifibrinolytics and antifibrinolytic-like agents for patients undergoing total hip and total knee arthroplasty | |
DK1240901T3 (da) | Medicinske præparater til behandling og forebyggelse af sygdomme baseret på abnorm blodkoagulation | |
DE60043346D1 (de) | Methoden zur hemmung der aktivität der osteoklasten | |
DE69934689D1 (de) | Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen | |
Rai et al. | Efficacy of feracrylum as topical hemostatic agent in therapeutically anticoagulated patients undergoing dental extraction: a comparative study | |
Bernet et al. | Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin‐treated patients | |
Tsolka | Dental procedures in patients with atrial fibrillation and new oral anticoagulants | |
FR2773712B1 (fr) | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a | |
NO20021410D0 (no) | Forebygging og behandling av blodkoagulasjons-relaterte sykdommer | |
WO2001011038A3 (en) | Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds | |
DE59909356D1 (de) | Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen | |
Krishnan et al. | Effects Of Haemostatic Agents On Bond Strength–An In Vitro Study | |
ATE337790T1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
MX9302986A (es) | Medicamento que contiene metrifonato y procedimiento para su preparacion |